Explore more publications!
Healthcare Wire Hong Kong
Got News to Share?

Press Releases

CoinEx Updates Latest Proof of Reserve, Reinforcing Its Commitment to Ensuring User Security
an hour ago

CoinEx Updates Latest Proof of Reserve, Reinforcing Its Commitment to Ensuring User Security

Indeterminate GlobeNewswire, Inc.
Jimmy Lai Triumphs in Appeal Over 2022 Fraud Case in Hong Kong
Feb. 26, 2026

Jimmy Lai Triumphs in Appeal Over 2022 Fraud Case in Hong Kong

Indeterminate MENAFN
Owner: Sawsan Dababneh

MENAFN

Indeterminate
Owned By Sawsan Dababneh through The Middle East North Africa Financial Network, Inc
Year Founded 2000
Website menafn.com
Domain Registration Year Indeterminate
Access Type open
Publication Location Jordan, Amman
Owner Country Jordan

We welcome your feedback!
If you have comments or corrections, let us know.

InnoCare’s next-generation TRKi Zurletrectinib Receives Priority Review for the Treatment of Pediatric Patients with Solid Tumors in China
5 hours ago

InnoCare’s next-generation TRKi Zurletrectinib Receives Priority Review for the Treatment of Pediatric Patients with Solid Tumors in China

Indeterminate GlobeNewswire, Inc.
Why some teens feel less happy: Sleep and mindfulness may hold the key
4 hours ago

Why some teens feel less happy: Sleep and mindfulness may hold the key

Neutral EIN Presswire
Santhera Announces Proposed Inclusion and Reimbursement of AGAMREE® (Vamorolone) within Spain’s National Health System for the Treatment of Duchenne Muscular Dystrophy
Feb. 27, 2026

Santhera Announces Proposed Inclusion and Reimbursement of AGAMREE® (Vamorolone) within Spain’s National Health System for the Treatment of Duchenne Muscular Dystrophy

Indeterminate GlobeNewswire, Inc.
Of Skin and Wellness Introduces the Matrix® Skin Renewal Platform: A Revolutionary Approach to Skin Health
Feb. 25, 2026

Of Skin and Wellness Introduces the Matrix® Skin Renewal Platform: A Revolutionary Approach to Skin Health

Neutral EIN Presswire
Mstone Partners Healthcare Joins Global Efforts to Raise Awareness for Rare Disease Day
Feb. 24, 2026

Mstone Partners Healthcare Joins Global Efforts to Raise Awareness for Rare Disease Day

Neutral EIN Presswire
Mstone Partners Healthcare Highlights Polaryx Therapeutics’ Latest Preclinical Data Shared at WORLDSymposium™ 2026
Feb. 23, 2026

Mstone Partners Healthcare Highlights Polaryx Therapeutics’ Latest Preclinical Data Shared at WORLDSymposium™ 2026

Neutral EIN Presswire
Ascentage Pharma to Participate in Three Upcoming Investor Conferences
Feb. 23, 2026

Ascentage Pharma to Participate in Three Upcoming Investor Conferences

Indeterminate GlobeNewswire, Inc.
Rosewood Hong Kong Expands 'BluUp Upskilling Programme' to Build Career Pathways for SEN Youth
Feb. 10, 2026

Rosewood Hong Kong Expands 'BluUp Upskilling Programme' to Build Career Pathways for SEN Youth

Neutral EIN Presswire
Norton Rose Fulbright appoints Mary Young as Global Co-Head of Life Sciences and Healthcare
Feb. 18, 2026

Norton Rose Fulbright appoints Mary Young as Global Co-Head of Life Sciences and Healthcare

Indeterminate GlobeNewswire, Inc.
NutriWorks® Amplifies Power of Holistic Healing with Traditional Chinese Medicine-Based RestoreGlow Reflexology Patches
Feb. 18, 2026

NutriWorks® Amplifies Power of Holistic Healing with Traditional Chinese Medicine-Based RestoreGlow Reflexology Patches

Neutral EIN Presswire
Drug Trials Snapshot: HYRNUO
Feb. 27, 2026

Drug Trials Snapshot: HYRNUO

Gov't Institution U.S. Food and Drug Administration
Owner: American Government

U.S. Food and Drug Administration

Gov't Institution
Owned By American Government through Department of Health and Human Services
Year Founded 1906
Website www.fda.gov
Domain Registration Year Indeterminate
Access Type open
Publication Location United States, Maryland, Silver Springs
Owner Country United States

We welcome your feedback!
If you have comments or corrections, let us know.

Ascentage Pharma to Participate in Guggenheim Emerging Outlook: Biotech Summit 2026
Feb. 9, 2026

Ascentage Pharma to Participate in Guggenheim Emerging Outlook: Biotech Summit 2026

Indeterminate GlobeNewswire, Inc.
ORYZON Reports Financial Results and Corporate Update for Quarter Ended December 31st, 2025
Feb. 27, 2026

ORYZON Reports Financial Results and Corporate Update for Quarter Ended December 31st, 2025

Indeterminate GlobeNewswire, Inc.
Ascentage Pharma Announces IND Clearance by the China CDE for BTK Degrader APG-3288
Feb. 5, 2026

Ascentage Pharma Announces IND Clearance by the China CDE for BTK Degrader APG-3288

Indeterminate GlobeNewswire, Inc.
Alvotech Announces Positive Top-Line Results from Pivotal Pharmacokinetic Study for Proposed Biosimilar to Entyvio®
Feb. 5, 2026

Alvotech Announces Positive Top-Line Results from Pivotal Pharmacokinetic Study for Proposed Biosimilar to Entyvio®

Indeterminate GlobeNewswire, Inc.
Natural Health Trends Reports Fourth Quarter and Full Year 2025 Financial Results
Feb. 4, 2026

Natural Health Trends Reports Fourth Quarter and Full Year 2025 Financial Results

Indeterminate GlobeNewswire, Inc.
Rêve Med Spa Introduces the Matrix® Skin Renewal Platform: A Revolutionary Approach to Skin Health
Feb. 3, 2026

Rêve Med Spa Introduces the Matrix® Skin Renewal Platform: A Revolutionary Approach to Skin Health

Neutral EIN Presswire
Opus Genetics to Participate in Upcoming Medical and Industry Conferences in February 2026
Feb. 2, 2026

Opus Genetics to Participate in Upcoming Medical and Industry Conferences in February 2026

Indeterminate GlobeNewswire, Inc.
Show More

Share us

on your social networks:
Facebook Facebook LinkedIn LinkedIn
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms & Conditions